| RS1553508187 |
BMPR2
|
Health Risk |
Pathogenic/Likely pathogenic |
Pulmonary arterial hypertension associated with congenital heart disease, Idiopathic and/or familial pulmonary arterial hypertension |
| RS1553508231 |
COL3A1
|
Health Risk |
Likely pathogenic |
— |
| RS1553508238 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1553508246 |
TTC21B
|
Health Risk |
Likely pathogenic |
Nephronophthisis, Jeune thoracic dystrophy |
| RS1553508321 |
BMPR2
|
Health Risk |
Likely pathogenic |
Primary pulmonary hypertension, Pulmonary arterial hypertension |
| RS1553508338 |
COL3A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1553508368 |
NEB
|
Health Risk |
Likely pathogenic |
Arthrogryposis multiplex congenita 6, Arthrogryposis multiplex congenita 6 |
| RS1553508463 |
COL3A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiovascular phenotype, Ehlers-Danlos syndrome |
| RS1553508473 |
COL3A1
|
Health Risk |
Pathogenic |
Congenital aneurysm of ascending aorta, Ehlers-Danlos syndrome |
| RS1553508534 |
COL3A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Connective tissue disorder, Ehlers-Danlos syndrome |
| RS1553508544 |
COL3A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1553508711 |
COL3A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, type 4 |
| RS1553508863 |
DYSF
|
Health Risk |
Likely pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS1553508957 |
COL3A1
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS1553508988 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS1553509010 |
CPS1
|
Health Risk |
Likely pathogenic |
Congenital hyperammonemia, type I |
| RS1553509023 |
CPS1
|
Health Risk |
Likely pathogenic |
Congenital hyperammonemia, type I |
| RS1553509187 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1553509193 |
COL3A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, type 4 |
| RS1553509208 |
COL3A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1553509300 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1553509303 |
CPS1
|
Health Risk |
Likely pathogenic |
Congenital hyperammonemia, type I |
| RS1553509391 |
COL3A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1553509397 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1553509401 |
COL3A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, type 4 |
| RS1553509404 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1553509430 |
COL3A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1553509630 |
COL3A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1553509661 |
CPS1
|
Health Risk |
Likely pathogenic |
Congenital hyperammonemia, type I |
| RS1553509726 |
COL3A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1553509744 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1553509869 |
COL3A1
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS1553509924 |
CPS1
|
Health Risk |
Pathogenic |
Congenital hyperammonemia, type I |
| RS1553509934 |
COL3A1
|
Health Risk |
Likely pathogenic |
— |
| RS1553509983 |
BMPR2
|
Health Risk |
Pathogenic |
Primary pulmonary hypertension, Primary pulmonary hypertension |
| RS1553509984 |
BMPR2
|
Health Risk |
Pathogenic |
Primary pulmonary hypertension, Primary pulmonary hypertension |
| RS1553509997 |
BMPR2
|
Health Risk |
Pathogenic |
Pulmonary hypertension, primary |
| RS1553510000 |
COL3A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, type 4 |
| RS1553510171 |
TBR1
|
Health Risk |
Likely pathogenic |
Moderate global developmental delay, Autistic behavior |
| RS1553510182 |
TBR1
|
Health Risk |
Likely pathogenic |
Attention deficit hyperactivity disorder, Moderate global developmental delay |
| RS1553510186 |
TBR1
|
Health Risk |
Likely pathogenic |
— |
| RS1553510215 |
TBR1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553510217 |
TBR1
|
Health Risk |
Likely pathogenic |
Severe global developmental delay, Autistic behavior |
| RS1553510219 |
TBR1
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with autism and speech delay, Intellectual developmental disorder with autism and speech delay |
| RS1553510280 |
TBR1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autistic behavior, Moderate global developmental delay |
| RS1553510301 |
TBR1
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe global developmental delay, Autistic behavior |
| RS1553510303 |
TBR1
|
Health Risk |
Likely pathogenic |
Moderate global developmental delay, Moderate global developmental delay |
| RS1553510313 |
TBR1
|
Health Risk |
Likely pathogenic |
Moderate global developmental delay, Autistic behavior |
| RS1553510385 |
TBR1
|
Health Risk |
Likely pathogenic |
Moderate global developmental delay, Autistic behavior |
| RS1553510472 |
TBR1
|
Health Risk |
Likely pathogenic |
— |
| RS1553510492 |
TBR1
|
Health Risk |
Pathogenic/Likely pathogenic |
Moderate global developmental delay, Atypical behavior |
| RS1553510520 |
CPS1
|
Health Risk |
Likely pathogenic |
Congenital hyperammonemia, type I |
| RS1553510677 |
TBR1
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with autism and speech delay, Intellectual developmental disorder with autism and speech delay |
| RS1553510679 |
TBR1
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with autism and speech delay, Intellectual developmental disorder with autism and speech delay |
| RS1553510680 |
TBR1
|
Health Risk |
Likely pathogenic |
Moderate global developmental delay, Autistic behavior |
| RS1553510944 |
CPS1
|
Health Risk |
Likely pathogenic |
Congenital hyperammonemia, type I |
| RS1553511083 |
CPS1
|
Health Risk |
Pathogenic |
Congenital hyperammonemia, type I |
| RS1553511175 |
TBR1
|
Health Risk |
Pathogenic/Likely pathogenic |
Moderate global developmental delay, Autistic behavior |
| RS1553511216 |
TBR1
|
Health Risk |
Likely pathogenic |
Severe global developmental delay, Autistic behavior |
| RS1553511224 |
TBR1
|
Health Risk |
Likely pathogenic |
Severe global developmental delay, 10 conditions |
| RS1553511226 |
TBR1
|
Health Risk |
Likely pathogenic |
Severe global developmental delay, Autistic behavior |
| RS1553511326 |
CPS1
|
Health Risk |
Likely pathogenic |
Congenital hyperammonemia, type I |
| RS1553511680 |
ALS2
|
Health Risk |
Pathogenic |
Infantile-onset ascending hereditary spastic paralysis, Infantile-onset ascending hereditary spastic paralysis |
| RS1553511785 |
CPS1
|
Health Risk |
Likely pathogenic |
Congenital hyperammonemia, type I |
| RS1553511789 |
CPS1
|
Health Risk |
Pathogenic |
Congenital hyperammonemia, type I |
| RS1553512225 |
CPS1
|
Health Risk |
Likely pathogenic |
Congenital hyperammonemia, type I |
| RS1553512393 |
COL5A2
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1553512523 |
BMPR2
|
Health Risk |
Pathogenic |
— |
| RS1553512642 |
CPS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital hyperammonemia, type I |
| RS1553512813 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1553512879 |
CERKL
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1553513387 |
CPS1
|
Health Risk |
Likely pathogenic |
Congenital hyperammonemia, type I |
| RS1553513429 |
CPS1
|
Health Risk |
Likely pathogenic |
Congenital hyperammonemia, type I |
| RS1553513433 |
CPS1
|
Health Risk |
Likely pathogenic |
Congenital hyperammonemia, type I |
| RS1553513437 |
CERKL
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Autosomal recessive retinitis pigmentosa |
| RS1553513641 |
ALS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Infantile-onset ascending hereditary spastic paralysis, Infantile-onset ascending hereditary spastic paralysis |
| RS1553513657 |
COL5A2
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1553513864 |
CPS1
|
Health Risk |
Pathogenic |
Congenital hyperammonemia, type I |
| RS1553513971 |
COL5A2
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1553514506 |
COL5A2
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1553514799 |
COL5A2
|
Health Risk |
Likely pathogenic |
— |
| RS1553515318 |
COL5A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS1553515430 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1553515435 |
CERKL
|
Health Risk |
Likely pathogenic |
Severe photosensitivity, Macular dystrophy |
| RS1553515438 |
LIPT1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1553515473 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1553515517 |
COL5A2
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1553515794 |
COL5A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS1553516241 |
TTC21B
|
Health Risk |
Pathogenic |
SHORT-RIB THORACIC DYSPLASIA 4 WITH POLYDACTYLY, SHORT-RIB THORACIC DYSPLASIA 4 WITH POLYDACTYLY |
| RS1553516443 |
CPS1
|
Health Risk |
Likely pathogenic |
Congenital hyperammonemia, type I |
| RS1553516660 |
CPS1
|
Health Risk |
Likely pathogenic |
Congenital hyperammonemia, type I |
| RS1553516687 |
TTC21B
|
Health Risk |
Pathogenic/Likely pathogenic |
Short-rib thoracic dysplasia 6 with or without polydactyly, Short-rib thoracic dysplasia 6 with or without polydactyly |
| RS1553516759 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1553517092 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1553517122 |
CPS1
|
Health Risk |
Likely pathogenic |
Congenital hyperammonemia, type I |
| RS1553517123 |
HOXD13
|
Health Risk |
Pathogenic |
— |
| RS1553517128 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1553517142 |
NEB
|
Health Risk |
Likely pathogenic |
— |
| RS1553517203 |
SCN3A
|
Health Risk |
Likely pathogenic |
— |
| RS1553517224 |
CPS1
|
Health Risk |
Likely pathogenic |
Congenital hyperammonemia, type I |